About The Study: Pulmonary vein isolation resulted in a statistically significant and clinically important decrease in atrial fibrillation burden at 6 months, with substantial improvements in symptoms and quality of life, compared with a sham procedure.
Corresponding Authors: To contact the corresponding authors, email Rick A. Veasey, MD, ( rick.veasey@nhs.net ) and Rajdip Dulai, MBBS, ( rajdip.dulai.21@ucl.ac.uk )
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.17921)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Media advisory: This study is being presented at the European Society of Cardiology Congress 2024.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.17921?guestAccessKey=1955189f-f7bc-47ad-8270-9c65bbd58c7c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090224
JAMA